Skip to main content

Table 1 Baseline demographics, presentations, tumor type, location, angiographic features, and management

From: Trans-arterial embolization of malignant tumor-related gastrointestinal bleeding: technical and clinical efficacy

Age (years) Mean ± SD mean age 55.5 years (range 42 - 69 years)
Sex (M/F) 9/5
Presentation
➢ Hematemesis 11 (78.4%)
➢ Melena 7 (50%)
Tumor type
➢ Gastric Adenocarcinoma 8 (57.1%)
➢ Gastric lymphoma 3 (21.5%)
➢ GIST 2 (14.3%)
➢ Colonic adenocarcinoma 1 (7.1%)
Bleeding location
➢ Gastric 11 (78.5%)
➢ Small Intestinal 3 (21.5%)
Angiographic features:
➢ Tumor blush 12 (85.7%)
➢ Neovascularity 9 (64.3%)
➢ Extravasation 2 (14.3%)
Management:
➢ TAE with gelatin sponge particles. 2/14 (14.3%)
➢ TAE with gelatin sponge particles and repeated procedure with PVA. 3/14 (21.5%)
➢ TAE with PVA particles. 8/14 (57.1%)